A quick guide your provider reviews your health before prescribing
63 In a large-scale real-world study, the use of GLP-1 receptor agonists in patients with T2DM was also shown to increase the risk of intestinal obstruction compared to sodiumglucose cotransporter-2 (SGLT-2) inhibitors
The 2016 Fibromyalgia Survey Criteria, a self-report tool, assesses pain distribution via the widespread pain index and symptom severity via the symptom severity scale, with the resulting Fibromyalgia Severity Score serving as a measure of central sensitization (6972)
93 In a randomized placebo-controlled trial that included 99 NASH patients, liver biopsies showed 22.4% of those treated with 700 mg silymarin three times daily for 48 weeks had a reduction in fibrosis versus only 6% who received placebo
Semaglutide, a long-acting GLP-1 analogue Authors: Kalra, S., & Kapoor, N
Cell 25 , 23422350 (2014)